Total Payments
$461,914
2024 Payments
$30,328
Companies
69
Transactions
2,406
Medicare Patients
8,135
Medicare Billing
$6.1M
Payment Breakdown by Category
Other$327,480 (70.9%)
Travel$49,590 (10.7%)
Food & Beverage$45,200 (9.8%)
Consulting$39,003 (8.4%)
Education$641.07 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $322,630 | 187 | 69.8% |
| Travel and Lodging | $49,590 | 227 | 10.7% |
| Food and Beverage | $45,200 | 1,951 | 9.8% |
| Consulting Fee | $39,003 | 23 | 8.4% |
| Honoraria | $4,850 | 3 | 1.0% |
| Education | $641.07 | 15 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $97,329 | 498 | $0 (2024) |
| PFIZER INC. | $89,275 | 396 | $0 (2024) |
| ABBVIE INC. | $58,896 | 320 | $0 (2024) |
| GlaxoSmithKline, LLC. | $49,559 | 123 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $32,904 | 74 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $26,702 | 102 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $23,735 | 79 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $13,839 | 51 | $0 (2019) |
| Genentech USA, Inc. | $13,395 | 79 | $0 (2024) |
| GENZYME CORPORATION | $11,764 | 42 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $30,328 | 313 | GlaxoSmithKline, LLC. ($9,121) |
| 2023 | $32,082 | 281 | AstraZeneca Pharmaceuticals LP ($10,903) |
| 2022 | $44,780 | 284 | ABBVIE INC. ($14,596) |
| 2021 | $47,670 | 286 | GlaxoSmithKline, LLC. ($13,938) |
| 2020 | $28,458 | 185 | Gilead Sciences, Inc. ($5,321) |
| 2019 | $85,796 | 396 | PFIZER INC. ($30,958) |
| 2018 | $88,344 | 378 | Amgen Inc. ($31,891) |
| 2017 | $104,455 | 283 | Amgen Inc. ($34,546) |
All Payment Transactions
2,406 individual payment records from CMS Open Payments — Page 1 of 97
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $9.65 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | PFIZER INC. | — | Food and Beverage | In-kind items and services | $73.44 | General |
| 12/12/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: Immunology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.05 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $60.67 | General |
| Category: Immunology | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/08/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Fresenius Kabi USA, LLC | — | Food and Beverage | In-kind items and services | $15.62 | General |
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: RESPIRATORY | ||||||
| 11/27/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $9.15 | General |
| Category: Immunology | ||||||
| 11/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: Inflammation | ||||||
| 11/21/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,831 | 122,406 | $5.3M | $1.3M |
| 2022 | 28 | 1,907 | 129,069 | $4.2M | $1.3M |
| 2021 | 32 | 2,287 | 158,441 | $4.4M | $1.6M |
| 2020 | 31 | 2,110 | 181,198 | $5.1M | $1.9M |
Total Patients
8,135
Total Services
591,114
Medicare Billing
$6.1M
Procedure Codes
115
All Medicare Procedures & Services
115 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 42 | 33,703 | $1.7M | $350,771 | 20.4% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2023 | 15 | 63,767 | $440,727 | $276,224 | 62.7% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2023 | 28 | 10,151 | $1.9M | $259,311 | 13.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 100 | 9,900 | $346,500 | $182,287 | 52.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 456 | 1,140 | $172,140 | $96,098 | 55.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 105 | 695 | $391,980 | $67,006 | 17.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 217 | 691 | $71,864 | $45,628 | 63.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 42 | 306 | $39,168 | $6,499 | 16.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 89 | 89 | $10,591 | $6,402 | 60.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 54 | 96 | $39,250 | $5,153 | 13.1% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 52 | 167 | $43,587 | $4,581 | 10.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 118 | 316 | $23,068 | $3,235 | 14.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 103 | 104 | $5,616 | $3,094 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,890 | $2,905 | 42.2% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 57 | 57 | $46,626 | $2,076 | 4.5% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 66 | 136 | $2,284 | $1,165 | 51.0% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 14 | 20 | $6,200 | $949.83 | 15.3% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 51 | 165 | $4,125 | $691.78 | 16.8% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 17 | 17 | $2,926 | $580.60 | 19.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 11 | 39 | $4,680 | $457.12 | 9.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 20 | 21 | $1,344 | $413.67 | 30.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 13 | 65 | $1,170 | $374.85 | 32.0% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 112 | 676 | $6,760 | $343.92 | 5.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 23 | 59 | $708.00 | $317.46 | 44.8% |
| J3262 | Injection, tocilizumab, 1 mg | Office | 2022 | 19 | 69,482 | $485,541 | $301,110 | 62.0% |
About Dr. Mark Box, MD
Dr. Mark Box, MD is a Rheumatology healthcare provider based in Kansas City, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477604817.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Box, MD has received a total of $461,914 in payments from pharmaceutical and medical device companies, with $30,328 received in 2024. These payments were reported across 2,406 transactions from 69 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($322,630).
As a Medicare-enrolled provider, Box has provided services to 8,135 Medicare beneficiaries, totaling 591,114 services with total Medicare billing of $6.1M. Data is available for 4 years (2020–2023), covering 115 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Other Specialties Rheumatology
- Location Kansas City, MO
- Active Since 01/14/2007
- Last Updated 03/22/2021
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1477604817
Products in Payments
- Enbrel (Biological) $57,395
- BENLYSTA (Biological) $49,532
- XELJANZ (Drug) $38,999
- INFLECTRA (Biological) $37,827
- SAPHNELO (Biological) $32,534
- RINVOQ (Biological) $29,280
- COSENTYX (Biological) $23,604
- ORENCIA (Biological) $20,395
- ACTHAR (Biological) $14,396
- Humira (Biological) $14,395
- Actemra (Biological) $12,850
- LYRICA (Drug) $7,794
- KEVZARA (Drug) $7,682
- KEVZARA (Biological) $7,463
- SKYRIZI (Biological) $6,181
- TREMFYA (Drug) $5,816
- HUMIRA (Biological) $4,871
- Tavneos (Drug) $4,724
- Prolia (Biological) $3,943
- TAVNEOS (Drug) $3,484
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Kansas City
Thomas Scott, M.d, M.D
Rheumatology — Payments: $163,330
Rheumatology $163,330
John Ervin, Md, MD
Rheumatology — Payments: $130,602
Rheumatology $130,602
Dr. Shashank Radadiya, Md, MD
Rheumatology — Payments: $95,431
Rheumatology $95,431
Ghaith Noaiseh, Md, MD
Rheumatology — Payments: $21,392
Rheumatology $21,392
Cameron Jones, Md, MD
Rheumatology — Payments: $3,094
Rheumatology $3,094
Dr. David John, Md, MD
Rheumatology — Payments: $1,325
Rheumatology $1,325